col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


160 Results       Page 1

 [1] 
Elsevier: iScience
  original article Date Title Authors   All Authors
1 [GO] 2022―May―19 Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants Yaning Li, Qing Fan, Bing Zhou, Yaping Shen, Yuanyuan Zhang, Lin Cheng, et al. (+6)
2 [GO] 2022―May―18 Pearson’s patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreak Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Huiling Luo, Fang Fang, et al. (+8)
3 [GO] 2022―May―04 SARS-CoV-2-related pangolin coronavirus exhibits similar infection characteristics to SARS-CoV-2 and direct contact transmissibility in hamsters Zhendong Guo, Cheng Zhang, Chunmao Zhang, Huan Cui, Zhaoliang Chen, Xinyun Jiang, et al. (+8)
4 [GO] 2022―Apr―28 EVIDENCE SHOWING LIPOTOXICITY WORSENS OUTCOMES IN COVID-19 PATIENTS AND INSIGHTS ABOUT THE UNDERLYING MECHANISMS Rodrigo Cartin-Ceba, Biswajit Khatua, Bara El-Kurdi, Shubham Trivedi, Sergiy Kostenko, Zaid Imam, et al. (+16)
5 [GO] 2022―Apr―27 Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection Qiqi Zeng, Xin Qi, Junpeng Ma, Fang Hu, Xiaorui Wang, Hongyu Qin, et al. (+20)
6 [GO] 2022―Apr―26 The effect of the Delta SARS-CoV-2 variant in maternal infection and pregnancy Athina Samara, Asma Khalil, Patrick O’ Brien, Eric Herlenius
7 [GO] 2022―Apr―25 Inhibitors of dihydroorotate dehydrogenase cooperate with Molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication Kim M. Stegmann, Antje Dickmanns, Natalie Heinen, Claudia Blaurock, Tim Karrasch, Angele Breithaupt, et al. (+19)
8 [GO] 2022―Apr―11 Synthetic Carbohydrate Binding Agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2. Oscar Francesconi, Lorena Donnici, Marco Fragai, Elisa Pesce, Mauro Bombaci, Alessandra Fasciani, et al. (+6)
9 [GO] 2022―Apr―11 Inflammatory Responses in the Placenta upon SARS-CoV-2 Infection Late in Pregnancy Lissenya B. Argueta, Lauretta A. Lacko, Yaron Bram, Takuya Tada, Lucia Carrau, André Figueiredo Rendeiro, et al. (+20)
10 [GO] 2022―Apr―08 The value of longitudinal clinical data and paired CT scans in predicting the deterioration of COVID-19 revealed by an artificial intelligence system Xiaoyang Han, Ziqi Yu, Yaoyao Zhuo, Botao Zhao, Yan Ren, Lorenz Lamm, et al. (+6)
11 [GO] 2022―Apr―04 Unraveling the motivational secrets of honey bee foraging during the COVID pandemic Louise Bestea, Marco Paoli, Patrick Arrufat, Brice Ronsin, Julie Carcaud, Jean-Christophe Sandoz, et al. (+3)
12 [GO] 2022―Apr―02 Poly(I:C) Enhances Mesenchymal Stem Cell Control of Myeloid Cells From COVID-19 Patients Luciana Souza-Moreira, Yuan Tan, Yan Wang, Jia-Pey Wang, Mahmoud Salkhordeh, Jennifer Virgo, et al. (+7)
13 [GO] 2022―Mar―26 Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil Tiago Gräf, Gonzalo Bello, Felipe Gomes Naveca, Marcelo Gomes, Vanessa Leiko Oikawa Cardoso, Alexandre Freitas da Silva, et al. (+13)
14 [GO] 2022―Mar―22 Identified human breastmilk compositions effectively inhibit SARS-CoV-2 and variants infection and replication Xinyuan Lai, Yanying Yu, Wei Xian, Fei Ye, Xiaohui Ju, Yuqian Luo, et al. (+8)
15 [GO] 2022―Mar―17 Computed Tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates Thibaut Naninck, Nidhal Kahlaoui, Julien Lemaitre, Pauline Maisonnasse, Antoine De Mori, Quentin Pascal, et al. (+14)
16 [GO] 2022―Mar―17 Mono- and combinational drug therapies for global viral pandemic preparedness Aleksandr Ianevski, Rouan Yao, Ronja M. Simonsen, Vegard Myhre, Erlend Ravlo, Gerda D. Kaynova, et al. (+12)
17 [GO] 2022―Mar―14 Association of high SARS-CoV-2 RNAemia with diabetes and mortality in COVID-19 critically ill patient. Mehran Monchi, Thomas Bruneau, Sebastien Jochmans, David Veyer, Aurelia Pitsch, Olivier Ellrodt, et al. (+6)
18 [GO] 2022―Mar―11 RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants Qingtai Liang, Yifeng Wang, Shuyuan Zhang, Jing Sun, Wenbo Sun, Jizhou Li, et al. (+21)
19 [GO] 2022―Mar―11 Detection of SARS-CoV-2 with RAPID: a prospective cohort study Marcelo D.T. Torres, Lucas F. de Lima, André L. Ferreira, William R. de Araujo, Paul Callahan, Antonio Dávila, et al. (+2)
20 [GO] 2022―Mar―10 ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis Jinhuan Wei, Rui Shang, Jiaqi Wang, Shengze Zhu, JianQiang Yin, Ying Chen, et al. (+2)
21 [GO] 2022―Mar―07 An artificial intelligence deep learning platform achieves high diagnostic accuracy for Covid-19 pneumonia by reading chest X-ray images Dongguang Li, Shaoguang Li
22 [GO] 2022―Feb―26 When do children avoid infection risks: Lessons for schools during the COVID-19 pandemic Nina H. Fefferman, Katy-Ann Blacker, Charles A. Price, Vanessa LoBue
23 [GO] 2022―Feb―23 Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern Anuradha Rao, Leda Bassit, Jessica Lin, Kiran Verma, Heather B. Bowers, Kimberly Pachura, et al. (+10)
24 [GO] 2022―Feb―22 Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses Zhao Ni Wang, Xiang Sheng Yang, Jing Sun, Jin Cun Zhao, Nan Shan Zhong, Xiao Xiao Tang
25 [GO] 2022―Feb―22 A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants Jules B. Weinstein, Timothy A. Bates, Hans C. Leier, Savannah K. McBride, Eric Barklis, Fikadu G. Tafesse
26 [GO] 2022―Feb―19 No substantial pre-existing B cell immunity against SARS-CoV-2 in healthy adults Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, Nareshkumar Poopalasingam, Susanne Detmer, Manuel Koch, et al. (+14)
27 [GO] 2022―Feb―17 Impact of New Variants on SARS-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein Interactions Mary Hongying Cheng, James M. Krieger, Anupam Banerjee, Yufei Xiang, Burak Kaynak, Yi Shi, et al. (+2)
28 [GO] 2022―Feb―17 SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response Chanchan Xiao, Lipeng Mao, Zhigang Wang, Lijuan Gao, Guodong Zhu, Jun Su, et al. (+12)
29 [GO] 2022―Feb―12 Modeling potential impact of COVID-19 pandemic on global electric vehicle supply chain Xin Sun, Gang Liu, Han Hao, Zongwei Liu, Fuquan Zhao
30 [GO] 2022―Feb―05 Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa Olayinka Sunday Okoh, Nicholas Israel Nii-Trebi, Abdulrokeeb Jakkari, Tosin Titus Olaniran, Tosin Yetunde Senbadejo, Anna Aba Kafintu-kwashie, et al. (+10)
31 [GO] 2022―Feb―02 HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19 Liqun Zhang, Santosh K. Ghosh, Shrikanth C. Basavarajappa, Yinghua Chen, Pravesh Shrestha, Jackson Penfield, et al. (+4)
32 [GO] 2022―Jan―31 The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates the immunoregulatory/inflammatory signals Veronica Bordoni, Giulia Matusali, Davide Mariotti, Manuela Antonioli, Eleonora Cimini, Alessandra Sacchi, et al. (+9)
33 [GO] 2022―Jan―30 CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus Kazuto Yoshimi, Kohei Takeshita, Seiya Yamayoshi, Satomi Shibumura, Yuko Yamauchi, Masaki Yamamoto, et al. (+3)
34 [GO] 2022―Jan―28 Attenuation of SARS-CoV-2 Infection by Losartan in Human Kidney Organoids Waleed Rahmani, Hyunjae Chung, Sarthak Sinha, Maxwell Bui-Marinos, Rohit Arora, Arzina Jaffer, et al. (+3)
35 [GO] 2022―Jan―10 Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19. Nikhil Shri Sahajpal, Chi-Yu Jill Lai, Alex Hastie, Ashis K. Mondal, Siavash Raeisi Dehkordi, Caspar I. van der Made, et al. (+20)
36 [GO] 2022―Jan―07 Immunity to SARS-CoV-2 up to 15 months after infection Harold Marcotte, Antonio Piralla, Fanglei Zuo, Likun Du, Irene Cassaniti, Hui Wan, et al. (+27)
37 [GO] 2022―Jan―05 Neutralization of SARS-CoV-2 Delta variant is increased after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination Markus Bauswein, David Peterhoff, Annelie Plentz, Andreas Hiergeist, Ralf Wagner, André Gessner, et al. (+3)
38 [GO] 2022―Jan―01 SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics Karthik Ramachandran, Soumya Maity, Alagar R. Muthukumar, Soundarya Kandala, Dhanendra Tomar, Tarek Mohamed Abd El-Aziz, et al. (+16)
39 [GO] 2021―Dec―31 ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection Zai Wang, Tingting Deng, Yulian Zhang, Wenquan Niu, Qiangqiang Nie, Shengnan Yang, et al. (+5)
40 [GO] 2021―Dec―24 Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection Qi Cui, Gustavo Garcia, Mingzi Zhang, Cheng Wang, Hongzhi Li, Tao Zhou, et al. (+3)
41 [GO] 2021―Dec―24 Humoral and Cellular Immunogenicity two months after SARS-CoV-2 messenger RNA Vaccines in Patients with Cancer Natacha Bordry, Alfredo Addeo, Cyril Jaksic, Valérie Dutoit, Pascale Roux-Lombard, Dimpy P. Shah, et al. (+13)
42 [GO] 2021―Dec―20 Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19 Julie C. Wilson, David Kealy, Sally R. James, Tobias Plowman, Katherine Newling, Christopher Jagger, et al. (+15)
43 [GO] 2021―Dec―20 ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 Naoki Iwanaga, Laura Cooper, Lijun Rong, Nicholas J. Maness, Brandon Beddingfield, Zhongnan Qin, et al. (+13)
44 [GO] 2021―Dec―20 Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG Stephan Winklmeier, Katharina Eisenhut, Damla Taskin, Heike Rübsamen, Ramona Gerhards, Celine Schneider, et al. (+8)
45 [GO] 2021―Dec―10 Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike Bailey Lubinski, Maureen H.V. Fernandes, Laura Frazier, Tiffany Tang, Susan Daniel, Diego G. Diel, et al. (+2)
46 [GO] 2021―Dec―09 Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults Mònica Girona-Alarcon, Guillermo Argüello, Ana Esteve-Sole, Sara Bobillo-Perez, Xavier Paolo-Burgos, Elisenda Bonet-Carne, et al. (+6)
47 [GO] 2021―Dec―08 Standardized two-step testing of antibody activity in COVID-19 convalescent plasma Pavlo Gilchuk, Isaac Thomsen, Sandra Yoder, Eric Brady, James D. Chappell, Laura J. Stevens, et al. (+16)
48 [GO] 2021―Dec―04 SARS-CoV-2 Nucleocapsid protein attenuates stress granules and interacts with mRNAs to impair host stress response Syed Nabeel-Shah, Hyunmin Lee, Nujhat Ahmed, Giovanni L. Burke, Shaghayegh Farhangmehr, Kanwal Ashraf, et al. (+10)
49 [GO] 2021―Dec―03 Global Changes in Electricity Consumption During COVID-19 Elizabeth Buechler, Siobhan Powell, Tao Sun, Nicolas Astier, Chad Zanocco, Jose Bolorinos, et al. (+3)
50 [GO] 2021―Dec―03 Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication Elizabeth Geerling, Amanda N. Pinski, Taylor E. Stone, Richard J. DiPaolo, Michael Z. Zulu, Kevin J. Maroney, et al. (+3)
51 [GO] 2021―Dec―02 Tracking the amino acid changes of spike proteins across diverse host species of severe acute respiratory syndrome coronavirus 2 Srinivasulu Yerukala Sathipati, Sanjay K. Shukla, Shinn-Ying Ho
52 [GO] 2021―Nov―27 A Deep Learning Approach for Predicting Severity of COVID-19 Patients Using A Parsimonious Set of Laboratory Markers Vivek Singh, Rishi Kamaleswaran, Donald Chalfin, Antonio Buño-Soto, Janika San Roman, Edith Rojas-Kenney, et al. (+5)
53 [GO] 2021―Nov―27 Host parameters and mode of infection influence outcome in SARS-CoV-2 infected hamsters Bryan D. Griffin, Bryce M. Warner, Mable Chan, Emelissa Valcourt, Nikesh Tailor, Logan Banadyga, et al. (+23)
54 [GO] 2021―Nov―19 Pannexin-1 channel opening is critical for COVID-19 pathogenesis Ross Luu, Silvana Valdebenito, Eliana Scemes, Antonio Cibelli, David Spray, Maximiliano Rovegno, et al. (+11)
55 [GO] 2021―Nov―18 Fluvastatin mitigates SARS-CoV-2 infection in human lung cells Francisco J. Zapatero-Belinchón, Rebecca Moeller, Lisa Lasswitz, Marco van Ham, Miriam Becker, Graham Brogden, et al. (+11)
56 [GO] 2021―Nov―18 Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring towards glycolysis Hadar Medini, Amit Zirman, Dan Mishmar
57 [GO] 2021―Nov―17 Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2 Junpei Ohtsuka, Masaki Imai, Masayuki Fukumura, Mitsuyo Maeda, Asami Eguchi, Ryoichi Ono, et al. (+6)
58 [GO] 2021―Nov―11 Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test Susana Eyheramendy, Pedro A. Saa, Eduardo A. Undurraga, Carlos Valencia, Carolina López, Luis Méndez, et al. (+9)
59 [GO] 2021―Nov―11 Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors Lei Guo, Yan Liang, Heng Li, Huiwen Zheng, Zening Yang, Yanli Chen, et al. (+6)
60 [GO] 2021―Nov―10 Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells Ria Goswami, Veronica S. Russell, Joshua J. Tu, Charlene Thomas, Philip Hughes, Francine Kelly, et al. (+6)
61 [GO] 2021―Nov―01 Functional differences among the spike glycoproteins of multiple emerging SARS-CoV-2 variants of concern Qian Wang, Manoj S. Nair, Saumya Anang, Shijian Zhang, Hanh Nguyen, Yaoxing Huang, et al. (+3)
62 [GO] 2021―Oct―28 The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells Thushan I. de Silva, Guihai Liu, Benjamin B. Lindsey, Danning Dong, Shona C. Moore, Nienyun Sharon Hsu, et al. (+16)
63 [GO] 2021―Oct―25 Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19 Christoph Schultheiß, Lisa Paschold, Edith Willscher, Donjete Simnica, Anna Wöstemeier, Franziska Muscate, et al. (+6)
64 [GO] 2021―Oct―25 Partial Resistance of SARS-CoV-2 Delta Variants to Vaccine-elicited Antibodies and Convalescent sera Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau
65 [GO] 2021―Oct―25 DCcov: Repositioning of Drugs and Drug Combinations for SARS-CoV-2 Infected Lung through Constraint-Based Modeling Ali Kishk, Maria Pires Pacheco, Thomas Sauter
66 [GO] 2021―Oct―25 Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency Luis Eduardo R. Cunha, Adilson A. Stolet, Marcelo A. Strauch, Victor A.R. Pereira, Carlos H. Dumard, Andre M.O. Gomes, et al. (+27)
67 [GO] 2021―Oct―22 Endonuclease-based genotyping of the RBM as a method to track the emergence or evolution of SARS-CoV-2 variants Eva Lopez, Margot Barthélémy, Cécile Baronti, Shirley Masse, Alessandra Falchi, Fabien Durbesson, et al. (+4)
68 [GO] 2021―Oct―19 Effective chimeric antigen receptor T-cells (CAR-Ts) against SARS-CoV-2 Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, H. Uri Saragovi, Christopher E. Rudd
69 [GO] 2021―Oct―16 Increased gaze cueing of attention during COVID-19 lockdown Mario Dalmaso, Luigi Castelli, Giovanni Galfano
70 [GO] 2021―Oct―14 The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor Chuncui Huang, Zeshun Tan, Keli Zhao, Wenjun Zou, Hui Wang, Huanyu Gao, et al. (+4)
71 [GO] 2021―Oct―08 Inequitable and Heterogeneous Impacts on Electricity Consumption from COVID-19 Mitigation Measures Jiehong Lou, Yueming (Lucy) Qiu, Arthur Lin Ku, Destenie Nock, Bo Xing
72 [GO] 2021―Oct―07 Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease Bryce M. Warner, Lisa A. Santry, Alexander Leacy, Mable Chan, Phuc H. Pham, Robert Vendramelli, et al. (+26)
73 [GO] 2021―Oct―04 6-Thioguanine Blocks SARS-CoV-2 Replication by Inhibition of PLpro Caleb D. Swaim, Varun Dwivedi, Yi-Chieh Perng, Xu Zhao, Larissa A. Canadeo, Houda H. Harastani, et al. (+5)
74 [GO] 2021―Oct―04 The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery. Eleni Syrimi, Eanna Fennell, Alex Richter, Pavle Vrljicak, Richard Stark, Sascha Ott, et al. (+17)
75 [GO] 2021―Sep―30 A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19 Friederike Krempe, Lara Schöler, Benjamin Katschinski, Anke Herrmann, Olympia E. Anastasiou, Carina Elsner, et al. (+6)
76 [GO] 2021―Sep―30 Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19 Na Wang, Marta Vuerich, Ahmadreza Kalbasi, Jonathon J. Graham, Eva Csizmadia, Zachary James Manickas Hill, et al. (+8)
77 [GO] 2021―Sep―30 A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity Huanhuan Zhu, Fang Zheng, Linxuan Li, Yan Jin, Yuxue Luo, Zhen Li, et al. (+19)
78 [GO] 2021―Sep―29 SARS-CoV-2 integral membrane proteins shape the serological responses of COVID-19 patients. Sophie Martin, Christopher Heslan, Gwénaële Jégou, Leif A. Eriksson, Matthieu Le Gallo, Vincent Thibault, et al. (+3)
79 [GO] 2021―Sep―27 The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium Jeong Yeon Ji, Ara Jo, Jina Won, Chan Hee Gil, Haeun Shin, Sujin Kim, et al. (+2)
80 [GO] 2021―Sep―16 The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, Peter AC. Wing, Mirjam Schilling, James M. Harris, et al. (+21)
81 [GO] 2021―Sep―11 5-Hydroxymethyltubercidin Exhibits Potent Antiviral Activity against Flaviviruses and Coronaviruses, including SARS-CoV-2 Kentaro Uemura, Haruaki Nobori, Akihiko Sato, Takao Sanaki, Shinsuke Toba, Michihito Sasaki, et al. (+9)
82 [GO] 2021―Sep―10 An Interactive Single Cell Web Portal Identifies Gene and Cell Networks in COVID-19 Host Responses Kang Jin, Eric E. Bardes, Alexis Mitelpunkt, Jake Y. Wang, Surbhi Bhatnagar, Soma Sengupta, et al. (+3)
83 [GO] 2021―Sep―02 Development of humoral and cellular immunological memory against SARS-CoV-2 despite B-cell depleting treatment in multiple sclerosis. Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, Anna Månberg, Sophia Hober, Guro Gafvelin, et al. (+6)
84 [GO] 2021―Aug―31 One common enemy, a pandemic, uniting interdisciplinary teams Marie-Elizabeth Barabas, Rituparna Chakrabarti, Michelle Muzzio
85 [GO] 2021―Aug―26 Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2 Xingyue An, Melisa Martinez-Paniagua, Ali Rezvan, Samiur Rahman Sefat, Mohsen Fathi, Shailbala Singh, et al. (+5)
86 [GO] 2021―Aug―25 Single Cell Transcriptome Identifies FCGR3B Upregulated Subtype of Alveolar Macrophages in Patients with Critical COVID-19 Nasna Nassir, Richa Tambi, Asma Bankapur, Saba Al Heialy, Noushad Karuvantevida, Hamdah Hassan Khansaheb, et al. (+24)
87 [GO] 2021―Aug―20 Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern Juanjie Tang, Youri Lee, Supriya Ravichandran, Gabrielle Grubbs, Chang Huang, Charles B. Stauft, et al. (+4)
88 [GO] 2021―Aug―11 Distinct Lipid Metabolic Dysregulation in Asymptomatic COVID-19 Yanhong Hao, Zheng Zhang, Guifang Feng, Moran Chen, Qiongqiong Wan, Jie Lin, et al. (+3)
89 [GO] 2021―Aug―09 Sensitive extraction-free SARS-CoV-2 RNA virus detection using a chelating resin Bin Guan, Karen M. Frank, José O. Maldonado, Margaret Beach, Eileen Pelayo, Blake M. Warner, Robert B. Hufnagel
90 [GO] 2021―Aug―04 Immunogenicity and Protective Efficacy of an Intranasal Live-attenuated Vaccine Against SARS-CoV-2 Jun-Guy Park, Fatai S. Oladunni, Mohammed A. Rohaim, Jayde Whittingham-Dowd, James Tollitt, Matthew D.J. Hodges, et al. (+13)
91 [GO] 2021―Jul―31 Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, Masood A. Shariff, Gagandeep Singh, Vidya Menon, Florian Krammer
92 [GO] 2021―Jul―30 JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules Jakub Jankowski, Hye Kyung Lee, Julia Wilflingseder, Lothar Hennighausen
93 [GO] 2021―Jul―26 A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes Daniel Todt, Toni Luise Meister, Barbora Tamele, John Howes, Dajana Paulmann, Britta Becker, et al. (+12)
94 [GO] 2021―Jul―22 Effect of time and titer in convalescent plasma therapy for COVID-19 Paola de Candia, Francesco Prattichizzo, Silvia Garavelli, Rosalba La Grotta, Annunziata De Rosa, Agostina Pontarelli, et al. (+3)
95 [GO] 2021―Jul―21 A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples Tiantian Liu, Zhong Chen, Wanqiu Chen, Xin Chen, Maryam Hosseini, Zhaowei Yang, et al. (+6)
96 [GO] 2021―Jul―14 The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir Yan Zhao, Jing Sun, Yunfei Li, Zhengxuan Li, Yu Xie, Ruoqing Feng, et al. (+2)
97 [GO] 2021―Jul―10 Sensor Array and Gas Chromatographic Detection of the Blood Serum Volatolomic Signature of COVID-19 Yolande Ketchanji Mougang, Lorena Di Zazzo, Marilena Minieri, Rosamaria Capuano, Alexandro Catini, Jacopo Maria Legramente, et al. (+3)
98 [GO] 2021―Jul―09 Multi-Omics analysis of respiratory specimen characterizes baseline molecular determinants which associate with SARS-CoV-2 infection and outcome. Jaswinder Singh Maras, Shvetank Sharma, Adil Bhat, Sheetalnath Rooge, Reshu aggrawal, Ekta Gupta, Shiv K. Sarin
99 [GO] 2021―Jun―26 Graphene Nanoplatelet and Graphene Oxide Functionalization of Face Mask Materials Inhibits Infectivity of Trapped SARS-CoV-2 Flavio De Maio, Valentina Palmieri, Gabriele Babini, Alberto Augello, Ivana Palucci, Giordano Perini, et al. (+10)
100 [GO] 2021―Jun―24 Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance Patrick J. Lenehan, Eshwan Ramudu, A.J. Venkatakrishnan, Gabriela Berner, Reid McMurry, John C. O’Horo, et al. (+4)
101 [GO] 2021―Jun―24 ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion Qiangmin Zhang, Julia Gefter, W. Bruce Sneddon, Tatyana Mamonova, Peter A. Friedman
102 [GO] 2021―Jun―19 Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19 Marcel S. Woo, Friedrich Haag, Axel Nierhaus, Dominik Jarczak, Kevin Roedl, Christina Mayer, et al. (+14)
103 [GO] 2021―Jun―17 Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution Kalon J. Overholt, Jonathan R. Krog, Ivan Zanoni, Bryan D. Bryson
104 [GO] 2021―Jun―10 Disease-dependent interaction policies to support health and economic outcomes during the COVID-19 epidemic Guanlin Li, Shashwat Shivam, Michael E. Hochberg, Yorai Wardi, Joshua S. Weitz
105 [GO] 2021―Jun―10 CD177, a specific marker of neutrophil activation, is associated with COVID-19 severity and death Yves Lévy, Aurélie Wiedemann, Boris P. Hejblum, Mélany Durand, Cécile Lefebvre, Mathieu Surénaud, et al. (+17)
106 [GO] 2021―Jun―09 A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens Ebony N. Gary, Bryce M. Warner, Elizabeth M. Parzych, Bryan D. Griffin, Xizhou Zhu, Nikesh Tailor, et al. (+21)
107 [GO] 2021―Jun―01 Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain Chao Wu, Abraham J. Qavi, Asmaa Hachim, Niloufar Kavian, Aidan R. Cole, Austin B. Moyle, et al. (+10)
108 [GO] 2021―May―24 SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals Peter V. Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al Molawi, Reham Awni El Kahlout, Imtiaz Gilliani, et al. (+18)
109 [GO] 2021―May―18 Phenome-wide and eQTL Associations of COVID-19 Genetic Risk Loci Chang Moon, Brian M. Schilder, Towfique Raj, Kuan-lin Huang
110 [GO] 2021―May―07 Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids Huaying Zhao, Di Wu, Ai Nguyen, Yan Li, Regina C. Adão, Eugene Valkov, et al. (+3)
111 [GO] 2021―May―01 Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients Connor J. Dwyer, Colleen A. Cloud, Cindy Wang, Philip Heidt, Paramita Chakraborty, Tara F. Duke, et al. (+21)
112 [GO] 2021―Apr―26 Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses Arinjay Banerjee, Nader El-Sayes, Patrick Budylowski, Rajesh Abraham Jacob, Daniel Richard, Hassaan Maan, et al. (+22)
113 [GO] 2021―Apr―26 Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, et al. (+18)
114 [GO] 2021―Apr―21 Cell type resolved quantitative proteomics map of interferon response against SARS-CoV-2 Elisa Saccon, Xi Chen, Flora Mikaeloff, Jimmy Esneider Rodriguez, Laszlo Szekely, Beatriz Sá Vinhas, et al. (+7)
115 [GO] 2021―Apr―19 Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells Emi Sano, Sayaka Deguchi, Ayaka Sakamoto, Natsumi Mimura, Ai Hirabayashi, Yukiko Muramoto, et al. (+3)
116 [GO] 2021―Mar―19 Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 Immacolata Andolfo, Roberta Russo, Vito Alessandro Lasorsa, Sueva Cantalupo, Barbara Eleni Rosato, Ferdinando Bonfiglio, et al. (+15)
117 [GO] 2021―Mar―19 Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-COV-2 Ang Gao, Zhilin Chen, Assaf Amitai, Julia Doelger, Vamsee Mallajosyula, Emily Sundquist, et al. (+6)
118 [GO] 2021―Mar―14 The Silent Pandemic: Emergent Antibiotic Resistances Following the Global Response to SARS-CoV-2 Andrew R. Mahoney, Mohammad Moein Safaee, William M. Wuest, Ariel L. Furst
119 [GO] 2021―Mar―10 SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway Grant R. Campbell, Rachel K. To, Jonathan Hanna, Stephen A. Spector
120 [GO] 2021―Mar―10 Title: ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway Xiaoyuan Lin, Beibei Fu, Songna Yin, Zhifeng Li, Huawen Liu, Haiwei Zhang, et al. (+12)
121 [GO] 2021―Mar―07 A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection Jane E. Sinclair, Yanshan Zhu, Gang Xu, Wei Ma, Haiyan Shi, Kun-Long Ma, et al. (+9)
122 [GO] 2021―Mar―01 Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19 Qu Deng, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, Irfan A. Asangani
123 [GO] 2021―Feb―23 Heuristic Thinking and Altruism towards Machines in People Impacted by Covid-19 Celso M. de Melo, Jonathan Gratch, Frank Krueger
124 [GO] 2021―Feb―16 Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors Timothy S. Chang, Yi Ding, Malika K. Freund, Ruth Johnson, Tommer Schwarz, Julie M. Yabu, et al. (+6)
125 [GO] 2021―Feb―16 Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes Ziliang Zhou, Chunliu Huang, Zhechong Zhou, Zhaoxia Huang, Lili Su, Sisi Kang, et al. (+7)
126 [GO] 2021―Feb―10 Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz
127 [GO] 2021―Feb―07 Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy Wyler Emanuel, Mösbauer Kirstin, Franke Vedran, Diag Asija, Gottula Lina Theresa, Arsiè Roberto, et al. (+22)
128 [GO] 2021―Feb―06 Proteomic Investigation Reveals Dominant Alterations of Neutrophil Degranulation and mRNA Translation Pathways in COVID-19 Patients Renuka Bankar, Kruthi Suvarna, Saicharan Ghantasala, Arghya Banerjee, Deeptarup Biswas, Manisha Choudhury, et al. (+13)
129 [GO] 2021―Jan―28 Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity Alex Graudenzi, Davide Maspero, Fabrizio Angaroni, Rocco Piazza, Daniele Ramazzotti
130 [GO] 2021―Jan―22 The presentation of SARS-CoV-2 peptides by the common HLA-A*02:01 molecule Christopher Szeto, Demetra S.M. Chatzileontiadou, Andrea T. Nguyen, Hannah Sloane, Christian A. Lobos, Dhilshan Jayasinghe, et al. (+5)
131 [GO] 2021―Jan―20 The outbreak of COVID-19 altered the relationship between current negative memory biases and future depressive degree in nonclinical depression Pengyu Zhang, Yi Piao, Ying Chen, Jiecheng Ren, Longhua Zhang, Bensheng Qiu, et al. (+2)
132 [GO] 2021―Jan―12 A high-throughput liquid bead-array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity Monique Bennett, Sandra Yoder, Eric Brady, Jill M. Pulley, Jillian P. Rhoads, Thomas G. Stewart, et al. (+4)
133 [GO] 2021―Jan―10 A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening Christoph Gorgulla, Krishna M. Padmanabha Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zi-Fu Wang, et al. (+31)
134 [GO] 2020―Dec―27 High-Throughput Rational Design of the Remdesivir Binding Site in the RdRp of SARS-CoV-2: Implications for Potential Resistance Aditya K. Padhi, Rohit Shukla, Prakash Saudagar, Timir Tripathi
135 [GO] 2020―Dec―16 Transcriptomic Similarities and Differences in Host Response between SARS-CoV-2 and Other Viral Infections Simone A. Thair, Yudong D. He, Yehudit Hasin-Brumshtein, Suraj Sakaram, Rushika Pandya, Jiaying Toh, et al. (+13)
136 [GO] 2020―Dec―07 Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19 Lucy CK. Bell, Cem Meydan, Jacob Kim, Jonathan Foox, Daniel Butler, Christopher E. Mason, et al. (+3)
137 [GO] 2020―Dec―07 Structural characterization of Nonstructural protein 1 from SARS-CoV-2 Cameron Semper, Nobuhiko Watanabe, Alexei Savchenko
138 [GO] 2020―Nov―28 Remdesivir is effective in combating COVID-19 because it is a better substrate than ATP for the viral RNA-dependent RNA polymerase Tyler L. Dangerfield, Nathan Z. Huang, Kenneth A. Johnson
139 [GO] 2020―Nov―25 SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain Leon Fodoulian, Joel Tuberosa, Daniel Rossier, Madlaina Boillat, Chenda Kan, Véronique Pauli, et al. (+5)
140 [GO] 2020―Nov―13 Innate and adaptive immunity of murine neural stem cell-derived piRNA exosomes/microvesicles against pseudotyped SARS-CoV-2 and HIV-based lentivirus Bin Yu, Shoeb Ikhlas, Chunsheng Ruan, Xingxing Zhong, Dongsheng Cai
141 [GO] 2020―Oct―28 The SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and Furin proteases Lulin Zhou, Zubiao Niu, Xiaoyi Jiang, Zhengrong Zhang, You Zheng, Zhongyi Wang, et al. (+5)
142 [GO] 2020―Oct―26 Robust and specific secretory IgA against SARS-CoV-2 detected in human milk Alisa Fox, Jessica Marino, Fatima Amanat, Florian Krammer, Jennifer Hahn-Holbrook, Susan Zolla-Pazner, Rebecca L. Powell
143 [GO] 2020―Oct―05 Furin, a potential therapeutic target for COVID-19 Canrong Wu, Mengzhu Zheng, Yueying Yang, Xiaoxia Gu, Kaiyin Yang, Mingxue Li, et al. (+10)
144 [GO] 2020―Oct―05 Impact of COVID-19 measures on short-term electricity consumption in the most affected EU countries and USA states Javier López Prol, Sungmin O
145 [GO] 2020―Oct―05 SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum Chiara Bruzzone, Maider Bizkarguenaga, Rubén Gil-Redondo, Tammo Diercks, Eunate Arana, Aitor García de Vicuña, et al. (+13)
146 [GO] 2020―Sep―29 Mitochondria - in the crossfire of SARS-CoV-2 and immunity Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, Takumi Koshiba, Grégoire P. Millet
147 [GO] 2020―Sep―25 PPARγ cistrome repression during activation of lung monocyte-macrophages in severe COVID-19 Christophe Desterke, Ali G. Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli
148 [GO] 2020―Sep―23 SARS-CoV-2 infection boosts MX1 antiviral effector in COVID-19 patients Juan Bizzotto, Pablo Sanchis, Mercedes Abbate, Sofía Lage-Vickers, Rosario Lavignolle, Ayelén Toro, et al. (+6)
149 [GO] 2020―Sep―03 Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis Nilesh Kumar, Bharat Mishra, Adeel Mehmood, Mohammad Athar
150 [GO] 2020―Jul―31 ACE2, Metformin, and COVID-19 Atul Malhotra, Mark Hepokoski, Karen C. McCowen, John Y-J Shyy
151 [GO] 2020―Jul―28 The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3)
152 [GO] 2020―Jul―25 Molecular and immunological diagnostic tests of COVID-19 - current status and challenges Tugba Kilic, Ralph Weissleder, Hakho Lee
153 [GO] 2020―Jul―18 ACE2 co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic Maya Braun, Elad Sharon, Irene Unterman, Maya Miller, Anna Mellul Shtern, Shmuel Benenson, et al. (+2)
154 [GO] 2020―Jun―20 Current status of COVID-19 therapies and drug repositioning applications Ozlem Altay, Elyas Mohammadi, Simon Lam, Hasan Turkez, Jan Boren, Jens Nielsen, et al. (+2)
155 [GO] 2020―Jun―20 CORDITE: the curated CORona Drug InTERactions database for SARS-CoV-2 Roman Martin, Hannah F. Löchel, Marius Welzel, Georges Hattab, Anne-Christin Hauschild, Dominik Heider
156 [GO] 2020―Jun―09 Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9 Dene R. Littler, Benjamin S. Gully, Rhys N. Colson, Jamie Rossjohn
157 [GO] 2020―May―30 Mitigating coronavirus-induced acute respiratory distress syndrome by radiotherapy Jian Jian Li
158 [GO] 2020―May―28 Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site Javier A. Jaimes, Jean K. Millet, Gary R. Whittaker
159 [GO] 2020―May―13 The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3)
160 [GO] 2020―May―12 In the Race to Help with Covid-19, Time Is Precious: Editorial Guidelines for Coronavirus Papers Simona Fiorani, Stefano Tonzani
 [1] 

160 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.011 sec